Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

ZNTL stock profile - insider summary

Manage Columns
  1. Name
  2. Date
  3. Title
  4. Total Bought
  5. Total Sold
  6. Updated
  7. IssuerCik
  8. SubKey
  9. netTransacted
  1. Voliotis Dimitris
    2023/02/19
    SVP, Clinical Development
    119563
    -30601
    2023-02-19
    0001725160
    0001725160
    88962
  2. Epperly Melissa B,
    2023/02/18
    Chief Financial Officer
    459293
    -94611
    2023-02-18
    0001725160
    0001725160
    364682
  3. Voliotis Dimitris
    2023/02/17
    SVP, Clinical Development
    119563
    -30601
    2023-02-17
    0001725160
    0001725160
    88962
  4. Voliotis Dimitris
    2023/02/16
    SVP, Clinical Development
    119563
    -30601
    2023-02-16
    0001725160
    0001725160
    88962
  5. Viking Global Opportunities Illiquid Investments Sub-Master LP
    2023/02/15
    1450000
    -500000
    2023-02-15
    0001725160
    0001725160
    950000
  6. Viking Global Opportunities Illiquid Investments Sub-Master LP
    2023/02/14
    1450000
    -500000
    2023-02-14
    0001725160
    0001725160
    950000
  7. Recurium Equity, LLC
    2023/02/13
    -8295880
    2023-02-13
    0001725160
    0001725160
    -8295880
  8. Voliotis Dimitris
    2023/02/12
    SVP, Clinical Development
    119563
    -30601
    2023-02-12
    0001725160
    0001725160
    88962
  9. Voliotis Dimitris
    2023/02/11
    SVP, Clinical Development
    119563
    -30601
    2023-02-11
    0001725160
    0001725160
    88962
  10. Voliotis Dimitris
    2023/02/10
    SVP, Clinical Development
    119563
    -30601
    2023-02-10
    0001725160
    0001725160
    88962

Related News

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

QQQ ETF ($706.22) Slides 7.4% Below Its High as the Market Reprices the AI Capex Bill — $686.57 Target if $700 Breaks

TradingNEWS Archive 22.10.26
Stocks Markets AMZN MSFT NVDA META
META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

META ($660.00) Swings 12.1% From After-Hours High as Capex Floor Rises to $135B — $600 Target if $648.74 Breaks

Itai Smidt 22.10.26
Stocks META PINS SNAP RDDT
S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

S&P 500 7,757, Nasdaq 26,703, Dow 52,856 Face AI Selloff as META, TSLA, LRCX Slide

Itai Smidt 22.10.26
Stocks Markets IBM LRCX TSLA META
SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

SMCX ETF ($9.83) Delivers a Clean 2x Day on Super Micro’s Beat — Meta Capex and November 3 Cash Flow Decide $12.88 or $8.13

Itai Smidt 21.10.26
Stocks Markets SMCI MU NVDA AMD
NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

NFLX ($65.69) Trades at 19x Earnings Despite a 34.6% Margin — Path Back to $72.56 Needs Engagement Proof

Itai Smidt 21.10.26
Stocks NFLX WBD DIS AMZN
TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

TSLA ($386.95) Runs 9% in 4 Sessions on Merger Talk — Q3 Margins Decide $415 or $360

Itai Smidt 21.10.26
Stocks TSLA GM F TM
Trade Now
© Trading News. All Rights Reserved Since 2022